Search results for "iban"

showing 10 items of 133 documents

Copper quality and sources in Middle Bronze Age I Byblos and Tell Arqa (Lebanon)

2013

Abstract Forty-four Middle Bronze Age I weapons discovered at the sites of Byblos and Tell Arqa in Lebanon were investigated in order to study their copper quality and provenance. The evaluation of copper qualities is based on quantifying permanent inclusions such as copper sulfide and lead globules. The provenance of copper was studied using lead isotope analyses. For further discrimination between copper groups and sources elemental analyses by PIXE were performed on some of the weapons investigated. The results revealed two copper groups that could be qualified as “dirty” copper and “clean” copper. The former was used in most of the weapon types whereas the latter was reserved for items …

010506 paleontologyArcheologyProvenanceÂge du bronze Tell Arqa (Liban060102 archaeology[SHS.ARCHEO]Humanities and Social Sciences/Archaeology and PrehistoryManufacturing processchemistry.chemical_element06 humanities and the arts01 natural sciencesCopperArchaeologyCopper sulfidechemistry.chemical_compoundGeographychemistryBronze Age0601 history and archaeologyComputingMilieux_MISCELLANEOUS0105 earth and related environmental sciencessite archéologique)
researchProduct

Modelling prey-predator interactions in Messina beachrock pools

2020

Abstract The Strait of Messina (Sicily, Italy) attracts the interest of marine ecologists for the presence of a large variety of habitat and mutually-interacting communities. Among them, beachrock formations, despite their wide geographic distribution, which also includes the Mediterranean area, have been poorly investigated from the biotic viewpoint. In this paper, the spatial and seasonal variability of benthic megafauna from the Messina microtidal beachrock is described. Combining in situ collected data (measurements of abiotic parameters and underwater visual census) with theoretical post-processing analyses (analysis of similarity percentages and cluster analysis), we deduced the possi…

0106 biological sciencesBeachrockbiologyEcology010604 marine biology & hydrobiologyEcological ModelingBeachrock; Benthic community; Carrying capacity; Hopf bifurcation; Marine ecology; Prey-predator interactionPrey-predator interactionCarrying capacityHermit crabbiology.organism_classification010603 evolutionary biology01 natural sciencesClibanarius erythropusMarine ecologyGeographyHabitatBenthic communityBenthic zoneMegafaunaBeachrockEcosystemHopf bifurcationSettore MAT/07 - Fisica MatematicaTrophic level
researchProduct

Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey

2018

Abstract Background The Icatibant Outcome Survey (IOS; NCT01034969) is a Shire‐sponsored, international, observational study monitoring the safety and effectiveness of icatibant, a bradykinin B2 receptor antagonist approved for the acute treatment of adults with hereditary angioedema with C1 inhibitor deficiency (HAE‐C1‐INH). Objective To report IOS data comparing demographic and icatibant treatment outcomes in patients with HAE‐C1‐INH from Germany to HAE‐C1‐INH patients from 11 other IOS countries. Methods A descriptive, retrospective, comparative analysis of data from 685 IOS patients with HAE‐C1‐INH from seven centres in Germany (n = 93) vs. centres from Austria, Brazil, Czech Republic, …

0301 basic medicineAdultMalePediatricsmedicine.medical_specialtyTime FactorsC1 inhibitor deficiencyTime to treatmentDermatologyBradykininAutoimmune DiseasesTime-to-Treatment03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIcatibantGermanyBradykinin B2 Receptor AntagonistsmedicineHumansIn patientSymptom onsetRetrospective Studiesbusiness.industryAngioedemas HereditaryMiddle Agedmedicine.diseaseSymptom Flare UpHealth Surveys030104 developmental biologyInfectious Diseases030228 respiratory systemchemistryHereditary angioedemaObservational studyOriginal ArticleFemaleOutcome databusinessJournal of the European Academy of Dermatology and Venereology
researchProduct

Non-Radiation Based Early Pain Relief Treatment Options for Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: A Systematic Review

2020

Introduction: Cancer induced bone pain (CIBP) is frequent in patients with non-small cell lung cancer (NSCLC). Radiation therapy continues to be the gold standard for treatment of painful bone metastases, however only a limited number of metastases can be irradiated. We evaluated non-radiation based early CIBP relief options in NSCLC through a systematic review. Methods: Systematic review including all prospective articles published between 01-1994 and 06-2020 on Pubmed, Cochrane Library and ClinicalTrials.gov database. Inclusion: nonradiation based trials evaluating CIBP early pain relief options (initially defined as pain score evaluated within two weeks, because of no randomized trials, …

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentPain reliefcancer induced bone painCochrane Librarylcsh:RC254-282DISEASEpain relieflaw.inventionPALLIATIVE RADIOTHERAPY03 medical and health sciences0302 clinical medicineRandomized controlled trialSDG 3 - Good Health and Well-beingbone metastasessystematic reviewlawQUALITY-OF-LIFEInternal medicinemedicineLung cancerBone painIBANDRONATEbisphosphonatesnon-small cell lung cancerDENOSUMABbusiness.industryGold standardCancermedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensEFFICACYRadiation therapy1ST-LINE TREATMENT030104 developmental biologyMETASTASESOncology030220 oncology & carcinogenesisZOLEDRONIC ACIDmedicine.symptombusinessFrontiers in Oncology
researchProduct

The Burden of Respiratory Syncytial Virus Disease in Pre-Term Infants

2015

This mini-review summarises the risk factors for acquiring Respiratory Syncitial Virus (RSV) infection, and describes the harmful effects of the infection in pre-term infants. Moreover, theoretical considerations are discussed for the prevention of RSV infection in high-risk infant categories, such as pre-term infants. Background: Neonates positive for RSV are more prone to severe infection than neonates infected with other common respiratory viruses. Despite RSV infection being more common in late neonates than in early ones, pre-term infants ≤ 35 wk gestational age (GA) are at high risk for developing severe RSV disease. Efforts to prevent infection include case management, vaccination an…

0301 basic medicinemedicine.medical_specialtyPediatricsibandronateEnvironmental EngineeringSettore MED/17 - Malattie Infettivebusiness.industryVirus diseasesKeywords : OvariectomyIndustrial and Manufacturing EngineeringTerm (time)anti-oxidant enzyme03 medical and health sciences030104 developmental biology0302 clinical medicineSettore MED/38 - Pediatria Generale E Specialisticaestradiolrat’s liver.medicine030212 general & internal medicineRespiratory systemIntensive care medicinebusinessOvariectomy; estradiol; ibandronate; anti-oxidant enzymes; DEPPD free radical; rat’s liver. [Keywords]DEPPD free radical
researchProduct

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)

2006

Background In hereditary angioedema, bradykinin is assumed to be the most important mediator of edema formation. Objective To assess whether the selective bradykinin receptor-2 antagonist Icatibant is effective in acute edema attacks of hereditary angioedema. Methods In this uncontrolled pilot study, 15 patients with 20 attacks were treated with Icatibant. The attacks were analyzed by using a standardized and validated visual analog scale measurement and compared with historical data of untreated attacks. Plasma bradykinin concentration was measured before and 4 hours after intravenous Icatibant treatment. Results Symptom intensity decreased within 4 hours after administration of Icatibant;…

AdultMaleImmunologyBradykininPilot ProjectsBradykininchemistry.chemical_compoundEcallantideIcatibantBradykinin B2 Receptor AntagonistsHumansImmunology and AllergyMedicineAngioedemaBradykinin receptorBradykinin B2 Receptor AntagonistsAngioedemabusiness.industryGenetic Diseases InbornMiddle Agedmedicine.diseasechemistryAnesthesiaAcute DiseaseHereditary angioedemaFemalemedicine.symptomB2 Bradykinin Receptorbusinessmedicine.drugJournal of Allergy and Clinical Immunology
researchProduct

Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries.

2020

Background/methods At a consensus meeting in August 2018, pediatricians and dermatologists from German-speaking countries discussed the therapeutic strategy for the treatment of pediatric patients with type I and II hereditary angioedema due to C1 inhibitor deficiency (HAE-C1-INH) for Germany, Austria, and Switzerland, taking into account the current marketing approval status. HAE-C1-INH is a rare disease that usually presents during childhood or adolescence with intermittent episodes of potentially life-threatening angioedema. Diagnosis as early as possible and an optimal management of the disease are important to avoid ineffective therapies and to properly treat swelling attacks. This art…

Adultmedicine.medical_specialtyAdolescentImmunology610610 Medicine & healthLanadelumabDiseaseC1-inhibitorGermanPlasma03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIcatibantGermanymedicineHumansImmunology and Allergy030212 general & internal medicineAngioedemaChildIntensive care medicine610 Medicine & healthAngioedemabiologytreatmentbusiness.industryAngioedemas HereditaryC1-INH (C1 inhibitor)medicine.diseaselanguage.human_languagehereditary angioedemapediatric030228 respiratory systemchemistryconsensusPediatrics Perinatology and Child HealthHereditary angioedemalanguagebiology.proteinmedicine.symptombusinessComplement C1 Inhibitor Protein600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und GesundheitRare disease
researchProduct

Phytochemical and pharmacological properties of essential oils from Cedrus species

2017

Natural products frequently exert pharmacological activities. The present review gives an overview of the ethnobotany, phytochemistry and pharmacology of the Cedrus genus, e.g. cytotoxic, spasmolytic immunomodulatory, antiallergic, anti-inflammatory and analgesic activities. Cancer patients frequently seek remedies from traditional medicinal plants that are believed to exert less side effects than conventional therapy with synthetic drugs. A long-lasting goal of anti-cancer and anti-microbial therapy research is to find compounds with reduced side effects compared to currently approved drugs. In this respect, Cedrus species might be of interest. The essential oil isolated from Cedrus libani…

Antiproliferative activity; Cedrus atlantica; Cedrus deodara; Cedrus libani; essential oils; leukaemia cells; Pinaceae; Analytical Chemistry; Biochemistry; Plant Science; Organic ChemistryCedrus deodaraPhytochemicalsCedrus deodaraCedrus atlanticaAnti-Inflammatory Agentsleukaemia cellsAntiproliferative activityPlant Science01 natural sciencesBiochemistryCedruslaw.inventionNOAnalytical Chemistry03 medical and health sciences0302 clinical medicineAnti-Infective AgentslawOils VolatileHumansMedicinal plantsCedrusessential oilsEssential oilPolycyclic SesquiterpenesCedrus libaniPlants MedicinalTraditional medicinebiologyOrganic ChemistryCedrus libanibiology.organism_classificationPinaceaeAntineoplastic Agents Phytogenic0104 chemical sciencesPlant Leaves010404 medicinal & biomolecular chemistryPhytochemicalDrug development030220 oncology & carcinogenesisCedrus atlanticaSesquiterpenes
researchProduct

Sobre cerámicas Helenísticas en Iberia / Hispania. Significado y funcionalidad

2012

In this work we are going to take a chronological and typological tour by studying the iconography that appears in the Hellenistic wares imported from the Central and Oriental Mediterranean between 3rd and 2nd centuries BC in Hispania Citerior, in particular from Cartagena. We are going to analyze its functionality in the places of origin, and with the help of the Hispanic contexts we will conclude whether its presence here is a consequence of a certain commercial dynamic, or if it answers to a decorative preference, of taste or trend; even if the images are significant related to ritual or convivial uses, public or private, by the local inhabitant who acquires and uses them.

ArcheologyHistorymedia_common.quotation_subjectIconografía; cerámicas helenísticas; Gnathia; cuencos de relieves; fíalas; laginos; KlíbanosgnathiaIconography; Hellenistic wares; Gnathia; bowls of reliefs; phiales; lagynos; klibanosphialesHellenistic wareslcsh:CC1-960Iconographymedia_commoncuencos de relievescerámicas helenísticaslaginosTaste (sociology)bowls of reliefsArtPreferencefíalasiconografíaArchaeologyIconographylcsh:ArchaeologyEthnologyklibanosHumanitiesCC1-960lagynosklíbanosArchivo Español de Arqueología
researchProduct

Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.

2006

Platelet activation causes conformational changes of integrin GPIIb/IIIa (α IIb β 3 ), resulting in the exposure of its ligand-binding pocket. This provides the unique possibility to design agents that specifically block activated platelets only. We used phage display of single-chain antibody (scFv) libraries in combination with several rounds of depletion/selection to obtain human scFvs that bind specifically to the activated conformation of GPIIb/IIIa. Functional evaluation of these scFv clones revealed that fibrinogen binding to human platelets and platelet aggregation can be effectively inhibited by activation-specific scFvs. In contrast to clinically used GPIIb/IIIa blockers, which ar…

Blood PlateletsCarotid Artery DiseasesBleeding TimePhysiologyAmino Acid MotifsMolecular ConformationEptifibatidePlatelet Glycoprotein GPIIb-IIIa ComplexFerric CompoundsAntibodiesMiceChloridesFibrinolytic AgentsmedicineAbciximabAnimalsHumansPlateletPlatelet activationChemistryFibrinogen bindingFibrinogenThrombosisTirofibanPlatelet ActivationMolecular biologyComplementarity Determining RegionsMice Inbred C57BLTirofibanImmunologyEptifibatidePlatelet aggregation inhibitorTyrosineCardiology and Cardiovascular MedicineGlycoprotein IIb/IIIaPeptidesPlatelet Aggregation Inhibitorsmedicine.drugCirculation research
researchProduct